drugset
drugset / Trial / NCT06859957

Melatonin for Patients With Chronic Low Back Pain

NCT06859957 ↗

Phase 3 Recruiting 240 enrolled Bart Koes
RandomizedParallel-groupTriple-blindTreatment

Summary

Low back pain is one of the conditions causing more disability worldwide. The use of pain medications is substantial in patients with chronic LBP. But the efficacy of commonly used analgesics is modest. More than half of patients with chronic LBP also has sleep problems. In recent years, some preliminary studies have shown a promising effect of melatonin for the treatment of pain. The objective of this study is to investigate the efficacy of melatonin, relative to placebo, in patients with chronic LBP.

Timeline

Start
2025-04-11
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 10 mg —

Indications

No indication recorded.